LIA
AXDX

LS Investment Advisors’s Accelerate Diagnostics AXDX Stock Holding History

LS Investment Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed -$15K – 860
2020
Q2 		$15K Hold
100
– – ﹤0.01% 1455
2020
Q1 		$8K Hold
100
– – ﹤0.01% 1571
2019
Q4 		$17K Hold
100
– – ﹤0.01% 1562
2019
Q3 		$19K Hold
100
– – ﹤0.01% 1541
2019
Q2 		$23K Hold
100
– – ﹤0.01% 1499
2019
Q1 		$21K Buy
+100
New +$18.8K ﹤0.01% 1497

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

LS Investment Advisors's AXDX Position: Q3 2020 in Review

LS Investment Advisors sold out of Accelerate Diagnostics (AXDX) in Q3 2020, closing a stake of 100 shares — an estimated $15K sold.

LS Investment Advisors first reported a position in AXDX in Q1 2019 and held it in 6 quarters. The position peaked at $23K in Q2 2019. 112 funds tracked by Wall St. Rank hold AXDX as of Q3 2020.

  • LS Investment Advisors reported no remaining Accelerate Diagnostics position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 100 Accelerate Diagnostics shares in Q3 2020, an estimated $15K.
  • LS Investment Advisors first reported a position in Accelerate Diagnostics in Q1 2019 and held it in 6 quarters.
  • LS Investment Advisors's Accelerate Diagnostics position peaked at $23K in Q2 2019.
  • 112 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.